Abstract: The present disclosure relates to a method for preparing NK cells and an application thereof in treatment of a cancer. The present disclosure provides a pharmaceutical composition prepared from NK cells and a monoclonal antibody of CD105, which can be used for the treatment of colorectal cancer and has a good application prospect.
Type:
Grant
Filed:
January 24, 2022
Date of Patent:
October 31, 2023
Assignee:
SINO UNITED (BEIJING) BIOMEDICAL TECHNOLOGY CO., LTD.